AlphaCentric Life Sciences and Healthcare Fund is a registered fund series of MUTUAL FUND SERIES TRUST (series S000067055). Net assets $39.3M as of 2026-03-31.
Showing 15 of 63 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| First American Funds Inc. | — | $3.0M | 771.90% |
| Gilead Sciences Inc. | — | $2.8M | 718.07% |
| AstraZeneca PLC | — | $2.2M | 563.34% |
| Vertex Pharmaceuticals Incorporated | — | $2.2M | 559.96% |
| Ionis Pharmaceuticals, Inc. | — | $1.5M | 374.03% |
| Insmed Inc | — | $1.4M | 356.92% |
| Incyte Corporation. | — | $1.3M | 340.96% |
| Roivant Sciences Ltd | — | $1.3M | 335.78% |
| Argenx SE | — | $1.3M | 333.16% |
| Neurocrine Biosciences Inc | — | $1.3M | 321.86% |
| Axsome Therapeutics Inc. | — | $1.1M | 276.73% |
| Ascendis Pharma A/S | — | $1.0M | 263.27% |
| Apogee Therapeutics Inc. | — | $957K | 243.36% |
| Protagonist Therapeutics Inc | — | $953K | 242.31% |
| Amgen Inc. | — | $819K | 208.40% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $39.3M |
| 2025-12-31 | $37.0M |
| 2025-09-30 | $34.9M |
| 2025-06-30 | $34.4M |
| 2025-03-31 | $44.2M |
| 2024-12-31 | $52.7M |
| 2024-09-30 | $82.9M |
| 2024-06-30 | $82.8M |